Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Biochimica Et Biophysica Acta|April 25, 2015
Formation of fluorophores from the kynurenine pathway metabolite N-formylkynurenine and cyclic amines involves transamidation and carbon-carbon bond formation at the 2-position of the aminePetr Tomek, Brian D Palmer, Jackie D Kendall, et al.
Bioscience Reports|July 28, 2023
A pilot in vivo study: potential ovarian cancer therapeutic by placental extracellular vesiclesXinyue Chen, Sofian Tijono, Bridget Tsai, et al.
The Journal of Pathology|March 11, 2010
The role of autocrine TGFbeta1 in endothelial cell activation induced by phagocytosis of necrotic trophoblasts: a possible role in the pathogenesis of pre-eclampsiaQi Chen, Limei Chen, Bonnia Liu, et al.
Cancer Chemotherapy and Pharmacology|January 31, 2014
Efficacy against subcutaneous or intracranial murine GL261 gliomas in relation to the concentration of the vascular-disrupting agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), in the brain and plasmaRaymond Yung, Vahid Seyfoddin, Christopher Guise, et al.
Oncology Research|October 24, 2002
Uptake of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and activation of NF-kappaB in human tumor cell linesSee-Tarn Woon, Bruce C Baguley, Brian D Palmer, et al.
European Journal of Medicinal Chemistry|December 25, 2016
Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactionsPetr Tomek, Brian D Palmer, Jack U Flanagan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Thalidomide metabolites in mice and patients with multiple myelomaJun Lu, Brian D Palmer, Phillip Kestell, et al.
Biochemical Pharmacology|April 24, 2004
Induction of tumour necrosis factor and interferon-gamma in cultured murine splenocytes by the antivascular agent DMXAA and its metabolitesLiang-Chuan S Wang, Charu B Reddy, Bruce C Baguley, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 13, 2004
Metabolism of thalidomide in liver microsomes of mice, rabbits, and humansJun Lu, Nuala Helsby, Brian D Palmer, et al.
The Journal of Biological Chemistry|February 2, 2010
Activation of the nucleotide oligomerization domain signaling pathway by the non-bacterially derived xanthone drug 5'6-dimethylxanthenone-4-acetic acid (Vadimezan)Guanjun Cheng, Jing Sun, Zvi G Fridlender, et al.
Pageof 5